By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street
Suite 1A
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharma To Report First Quarter 2016 Financial Results And Recent Corporate Developments On Thursday, May 12 4/28/2016 11:20:13 AM
Catabasis Pharma Initiates Part B Of The MoveDMD Trial Of CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 4/12/2016 10:15:55 AM
Catabasis Pharma CFO Steps Down for Biopharma Startup 4/4/2016 6:08:58 AM
Catabasis Pharma To Present CAT-1004 Data From Part A Of The MoveDMD Trial At The 2016 Muscular Dystrophy Association Clinical Conference 3/18/2016 8:54:36 AM
Catabasis Pharma To Present At Cowen and Company’s 36th Annual Health Care Conference 3/3/2016 11:13:42 AM
Catabasis Pharma Reports Fourth Quarter And Full Year 2015 Financial Results And Recent Corporate Developments 3/3/2016 11:11:06 AM
Catabasis Pharma To Report Fourth Quarter And Full Year 2015 Financial Results And Recent Corporate Developments On Wednesday, March 2 2/17/2016 10:01:45 AM
Catabasis Pharma Will Present CAT-1004, A Potential Disease-Modifying Agent In Development For The Treatment Of Duchenne Muscular Dystrophy, At The XIV International Conference On Duchenne And Becker Muscular Dystrophy 2/10/2016 10:49:11 AM
Catabasis Pharma Will Present CAT-1004, A Potential Disease-Modifying Agent In Development For The Treatment Of Duchenne Muscular Dystrophy, At The XIV International Conference On Duchenne And Becker Muscular Dystrophy 2/10/2016 10:24:31 AM
Muscular Dystrophy Association To Collaborate With Catabasis Pharma On Development Of CAT-1004, A Potential Novel Oral Disease-Modifying Treatment For Duchenne Muscular Dystrophy 2/5/2016 9:14:39 AM
123456789
//-->